These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19926707)

  • 1. CT perfusion of head and neck cancer: why we should care versus why should we care!
    Mukherji SK; Castelijns JA
    AJNR Am J Neuroradiol; 2010 Mar; 31(3):391-3. PubMed ID: 19926707
    [No Abstract]   [Full Text] [Related]  

  • 2. PET-CT surveillance versus neck dissection in advanced head and neck cancer.
    Br Dent J; 2016 May; 220(9):449. PubMed ID: 27173700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.
    Connell CA; Corry J; Milner AD; Hogg A; Hicks RJ; Rischin D; Peters LJ
    Head Neck; 2007 Nov; 29(11):986-95. PubMed ID: 17563906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-CT for response assessment and treatment adaptation in head and neck cancer.
    Bussink J; van Herpen CM; Kaanders JH; Oyen WJ
    Lancet Oncol; 2010 Jul; 11(7):661-9. PubMed ID: 20226735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NI-RADS for head and neck cancer surveillance imaging: What, why, and how.
    Juliano AF; Aiken AH
    Cancer Cytopathol; 2020 Mar; 128(3):166-170. PubMed ID: 31750995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
    Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ
    AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging during radiotherapy of head and neck cancer.
    Menda Y; Buatti JM
    J Nucl Med; 2013 Apr; 54(4):497-8. PubMed ID: 23503730
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
    Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
    AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
    Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern Radiology in the Management of Head and Neck Cancer.
    Burkill GJ; Evans RM; Raman VV; Connor SE
    Clin Oncol (R Coll Radiol); 2016 Jul; 28(7):440-50. PubMed ID: 27156741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
    Paleri V; Zammit-Maempel I
    J Clin Oncol; 2010 Oct; 28(28):e515. PubMed ID: 20606098
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
    Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
    Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumour perfusion following treatment with water-filtered IR-A radiation to the thorax in a patient with head and neck cancer.
    Rich LJ; Winslow TB; Alberico RA; Repasky EA; Seshadri M; Singh AK
    Int J Hyperthermia; 2016 Aug; 32(5):539-42. PubMed ID: 27150820
    [No Abstract]   [Full Text] [Related]  

  • 16. Squamous Cell Carcinoma: PET/CT and PET/MRI of the Pretreatment and Post-Treatment Neck.
    Traylor KS; Koontz N; Mosier K
    Semin Ultrasound CT MR; 2019 Oct; 40(5):400-413. PubMed ID: 31635767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
    Mak D; Corry J; Lau E; Rischin D; Hicks RJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):487-99. PubMed ID: 22019706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Wang YF; Liu RS; Chu PY; Chang FC; Tai SK; Tsai TL; Huang JL; Chang SY
    Head Neck; 2009 Apr; 31(4):442-51. PubMed ID: 19177422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion CT of head and neck cancer.
    Razek AA; Tawfik AM; Elsorogy LG; Soliman NY
    Eur J Radiol; 2014 Mar; 83(3):537-44. PubMed ID: 24387935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck.
    Reiner B; Siegel E; Sawyer R; Brocato RM; Maroney M; Hooper F
    AJR Am J Roentgenol; 1997 Sep; 169(3):667-71. PubMed ID: 9275874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.